Kurt med. Kurt Rasche

Prof. Dr. Kurt med. Kurt Rasche

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in Life
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Inflammation and nutritional status are known to affect outcomes in patients with chronic obstructive pulmonary disease (COPD). However, their prognostic relevance in critically ill COPD patients remains unclear. This study investigated whether C-reactive protein (CRP), serum albumin, and the CRP/albumin ratio (CAR) were associated with in-hospital mortality in ICU patients with COPD. Methods: We conducted a retrospective cohort study using data from the MIMIC-IV database. Adult ICU patients with a diagnosis of COPD were included. We analyzed CRP, albumin, CAR, glucose, lactate, and creatinine. The primary outcome was in-hospital mortality. Multivariable logistic regression was used to identify variables that were independently associated with in-hospital mortality. Subgroup analyses stratified by age and sex were performed. Results: We included 1000 ICU patients with COPD. In-hospital mortality was 19.6%. In univariate analyses, glucose, creatinine, and lactate levels were significantly higher in non-survivors. In multivariable models, only elevated creatinine (OR 1.60, 95% CI 1.01–2.53) remained independently associated with mortality, while glucose was no longer statistically significant. CRP, albumin, and CAR were not significantly associated with in-hospital mortality. Subgroup analyses showed consistent results across age and sex strata. Conclusion: In critically ill COPD patients, glucose and creatinine levels upon ICU admission were independently associated with in-hospital mortality, whereas inflammation- and nutrition-related markers, such as CRP, albumin, and CAR, were not. However, given that albumin is heavily influenced by systemic inflammation, it cannot serve as a standalone nutritional marker in the ICU setting. Composite nutritional scores such as the Nutritional Risk Screening (NRS-2002) or the Global Leadership Initiative on Malnutrition (GLIM), which were not available in the MIMIC-IV database, may provide more accurate assessments. These findings highlight the need for integrated risk models incorporating metabolic and renal parameters for early prognostication.

14 March 2021
Verified
Book Chapter
Closed access
PDF file
RRRenan Viola Rasche
Renan Viola Rasche
FSFrauke Schuster
Frauke Schuster
NMNatalie Meurer
Natalie Meurer
TMTheodora Margariti
Theodora Margariti
NWNorbert Weyerbrock
Norbert Weyerbrock
CDCornelia Dotzenrath
Cornelia Dotzenrath

18 July 2025 in Neurology International
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Selective serotonin reuptake inhibitors (SSRIs) are among the most commonly prescribed antidepressants and are generally considered safe. However, emerging data suggest a potential association with intracranial hemorrhage (ICH), especially among elderly patients and those on anticoagulation. Methods: We conducted a retrospective pharmacovigilance analysis using data from the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS). Reports up to May 2025 listing an SSRI (sertraline, fluoxetine, paroxetine, escitalopram, citalopram, or fluvoxamine) as a suspect or interacting drug and involving an ICH event were included. Disproportionality was assessed using reporting odds ratios (RORs) with 95% confidence intervals. Results: Among 226 eligible ICH cases, sertraline (30.5%), paroxetine (28.8%), and fluoxetine (27.9%) were most frequently implicated. Sertraline showed a strong signal for cerebral hemorrhage (ROR = 4.97), while fluoxetine was associated with subarachnoid hemorrhage (ROR = 4.51). Sertraline had a pronounced signal among patients aged >60 years (ROR = 7.92) and in combination with anticoagulants (ROR = 9.56). Fluoxetine was underrepresented in elderly cases. Given the very small number of fluvoxamine-related cases (n = 2), interpretation should be cautious due to limited statistical power. Gender-stratified analyses showed female predominance in sertraline-related ICH and male predominance for paroxetine. Citalopram demonstrated a potentially protective profile with inverse association with cerebral hemorrhage. Conclusions: This study highlights significant differences in ICH reporting patterns across SSRIs, modified by patient age, gender, and co-medication. These findings underscore the need for individualized SSRI prescribing, particularly in patients receiving anticoagulant therapy particularly in elderly patients and those receiving anticoagulant therapy, where sertraline and fluoxetine may pose increased risk.

5 October 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Trelegy Ellipta is a widely prescribed triple inhaler therapy for chronic obstructive pulmonary disease (COPD). Although its clinical efficacy is well established, evidence on sex-specific differences in adverse event (AE) profiles from real-world pharmacovigilance data remains limited. In addition, some AEs may reflect underlying disease characteristics rather than drug exposure, which complicates interpretation of safety signals. Objective: To explore sex-related differences in AEs associated with Trelegy Ellipta using the FDA Adverse Event Reporting System (FAERS). The study aimed to identify potential safety signals while accounting for alternative explanations, including comorbidity burden and disease-related variation. Methods: We retrospectively analyzed FAERS reports from January 2018 to April 2025, identifying 4555 AEs attributed to Trelegy Ellipta. Events were coded by System Organ Class (SOC) and stratified by patient sex. Frequencies were compared between male (n = 1621) and female (n = 2934) patients using chi-square tests, and associations were expressed as reporting odds ratios (RORs) with 95% confidence intervals (CIs). Results: Male patients more frequently reported hypertension (63.4% vs. 47.0%; p = 0.01), pneumonia (87.8% vs. 76.8%; p < 0.001), anxiety (91.0% vs. 66.9%; p < 0.001), sleep disorders (20.1% vs. 6.8%; p < 0.001), and hyperglycemia (92.7% vs. 52.1%; p < 0.001). Female patients more often reported headache (56.7% vs. 32.6%; p < 0.001), depression (33.1% vs. 9.0%; p < 0.001), and osteoporosis (41.7% vs. 2.4%; p < 0.001). Further variation was observed across neurological, musculoskeletal, and respiratory categories, suggesting a multidimensional pattern of sex differences. Conclusions: This FAERS-based analysis indicates distinct sex-specific safety signals for Trelegy Ellipta, particularly in cardiovascular, neuropsychiatric, and steroid-related domains. These findings are hypothesis-generating and highlight the importance of incorporating sex-disaggregated analyses into future pharmacovigilance and clinical studies.

3 January 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Early administration of antibiotics is commonly recommended for pneumonia in intensive care unit (ICU) patients. However, the clinical benefit of very early empirical treatment remains uncertain and may reflect differences in illness severity, baseline risk, or care pathways, particularly in non-septic or hemodynamically stable ICU populations. Methods: We performed a retrospective cohort study using the Medical Information Mart for Intensive Care IV (v2.2) database to evaluate the observational association between antibiotic timing and in-hospital mortality among adult ICU patients with pneumonia. Patients were categorized as receiving early (<3 h) or delayed (≥3 h) antibiotic therapy after ICU admission. A multivariable logistic regression model adjusted only for age and sex. Given the absence of detailed severity-of-illness measures, no causal inference was intended, and all analyses were considered hypothesis-generating. Additional analyses exploring antibiotic class, dosing frequency, and combination therapy were conducted in an exploratory manner, given substantial variation in sample sizes and a high risk of confounding by indication, misclassification, immortal-time, and survivorship bias. Results: Among 7569 ICU patients with pneumonia, 56.5% received antibiotics within three hours of ICU admission. Early antibiotic initiation was associated with higher in-hospital mortality than delayed therapy (26.1% vs. 21.5%; OR 1.30, 95% CI 1.16–1.44; p < 0.001). Because validated severity-of-illness measures were unavailable, residual confounding and confounding by indication are likely and may largely explain this association. A potential signal of increased mortality was observed in patients receiving ≥3 doses of levofloxacin (OR 4.39, 95% CI 1.13–17.02); however, this subgroup was small and the finding is highly susceptible to survivorship and indication bias. Mortality appeared lower in patients receiving two or three antibiotics compared with monotherapy, but marked group imbalances, lack of restriction or stratification, and clinical selection effects limit interpretability. Regimens involving ≥4 agents were rare and primarily associated with prolonged ICU length of stay rather than a clear mortality difference. Conclusions: In this large retrospective ICU cohort, very early antibiotic administration for pneumonia was observationally associated with higher in-hospital mortality. Causality cannot be inferred, and early treatment likely represents a marker of higher baseline risk or clinical urgency rather than a harmful exposure. These findings challenge the assumption that earlier antibiotic initiation is uniformly beneficial and underscore the importance of individualized, stewardship-aligned, and context-dependent decision-making regarding antimicrobial timing and intensity in critically ill patients.

26 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Chest radiography remains a cornerstone of thoracic imaging; however, the influence of patient demographics and technical factors on radiologic findings is not yet fully understood. This study investigates how gender, age, and radiographic projection affect the prevalence of three common findings: atelectasis, pleural effusion, and pulmonary nodules. Methods: We analyzed 112,120 frontal chest radiographs from the publicly available NIH ChestX-ray8 dataset. Gender-specific prevalence rates were compared using chi-square tests and unadjusted odds ratios (ORs). Multivariable logistic regression was performed to assess the independent effects of gender, age, and projection (posteroanterior [PA] vs. anteroposterior [AP]), including interaction terms. Results: Atelectasis and nodules were more prevalent in male patients, with unadjusted rates of 10.9% and 5.8% versus 9.5% and 5.4% in females. While the difference in nodules’ prevalence was not statistically significant (OR = 0.96, p = 0.16), multivariable analysis showed a significant association (adjusted OR = 1.378, 95% CI 1.157–1.641; p = 0.0003). Pleural effusion showed no significant gender difference (11.7% vs. 12.1%; OR 0.97, p = 0.10). Increasing age was consistently associated with higher odds of all findings (ORs per year: 1.016–1.012; all p < 0.0001). The PA view reduced the odds of atelectasis (OR 0.59) and effusion (OR 0.60), but increased the odds of detecting nodules (OR 1.31). Interaction terms showed minor but statistically significant gender-related differences in age effects. Conclusions: Gender, age, and radiographic projection substantially affect the radiographic detection of frequently observed thoracic abnormalities. These findings are directly relevant for improving clinical diagnostic accuracy and for reducing demographic and technical biases in AI-based radiograph interpretation, particularly in critical care and screening settings.